Other
REACH
REACH is an intervention with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
COMBINATION PRODUCT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
60%(3 trials)
Phase Distribution
Ph not_applicable
5
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A5 (100.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completednot_applicable
Return to Everyday Activities in the Community and Home
NCT02786394
completednot_applicable
Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes
NCT02409329
completednot_applicable
REACH Personal Mobility Device Testing
NCT03847454
completednot_applicable
FAMS Mobile Health Intervention for Diabetes Self-care Support
NCT02481596
completednot_applicable
Changing Habits in Anorexia Nervosa: Novel Treatment Development
NCT02382055
Clinical Trials (5)
Showing 5 of 5 trials
NCT02786394Not Applicable
Return to Everyday Activities in the Community and Home
NCT02409329Not Applicable
Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes
NCT03847454Not Applicable
REACH Personal Mobility Device Testing
NCT02481596Not Applicable
FAMS Mobile Health Intervention for Diabetes Self-care Support
NCT02382055Not Applicable
Changing Habits in Anorexia Nervosa: Novel Treatment Development
All 5 trials loaded
Drug Details
- Intervention Type
- COMBINATION PRODUCT
- Total Trials
- 5